- Home
- HCWB vs USEA Comparison
HCWB vs USEA Comparison
Compare HCWB & USEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HCWB
- USEA
- Stock Information
- Founded
- HCWB 2018
- USEA 2004
- Country
- HCWB United States
- USEA Greece
- Employees
- HCWB N/A
- USEA N/A
- Industry
- HCWB Biotechnology: Pharmaceutical Preparations
- USEA Marine Transportation
- Sector
- HCWB Health Care
- USEA Consumer Discretionary
- Exchange
- HCWB Nasdaq
- USEA Nasdaq
- Market Cap
- HCWB 10.8M
- USEA 10.5M
- IPO Year
- HCWB 2021
- USEA N/A
- Fundamental
- Price
- HCWB $3.45
- USEA $1.58
- Analyst Decision
- HCWB Strong Buy
- USEA
- Analyst Count
- HCWB 1
- USEA 0
- Target Price
- HCWB $35.00
- USEA N/A
- AVG Volume (30 Days)
- HCWB 30.0K
- USEA 21.3K
- Earning Date
- HCWB 08-18-2025
- USEA 08-06-2025
- Dividend Yield
- HCWB N/A
- USEA 2.63%
- EPS Growth
- HCWB N/A
- USEA N/A
- EPS
- HCWB N/A
- USEA N/A
- Revenue
- HCWB $832,841.00
- USEA $42,625,000.00
- Revenue This Year
- HCWB $178.36
- USEA N/A
- Revenue Next Year
- HCWB N/A
- USEA $11.62
- P/E Ratio
- HCWB N/A
- USEA N/A
- Revenue Growth
- HCWB N/A
- USEA N/A
- 52 Week Low
- HCWB $2.77
- USEA $1.00
- 52 Week High
- HCWB $100.80
- USEA $2.78
- Technical
- Relative Strength Index (RSI)
- HCWB 31.06
- USEA 51.76
- Support Level
- HCWB $2.77
- USEA $1.50
- Resistance Level
- HCWB $4.65
- USEA $1.57
- Average True Range (ATR)
- HCWB 0.36
- USEA 0.07
- MACD
- HCWB -0.09
- USEA -0.01
- Stochastic Oscillator
- HCWB 36.22
- USEA 34.09
About HCWB HCW Biologics Inc.
HCW Biologics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company has developed TOBI discovery platform, or Tissue factor-based fusion discovery platform, for the design of category-defining immunotherapeutic drugs. It has selected two molecules as its product candidate; HCW9218 and HCW9302. HCW9218 is a bifunctional immunotherapeutic designed with the capabilities to neutralize transforming growth and stimulate immune cells. HCW9302 is designed to activate and expand regulatory T cells, which deactivate inflammasomes.
About USEA United Maritime Corporation
United Maritime Corp operates as a shipping company currently specializing in the seaborne transportation of dry bulk commodities. It currently operates one LR2 tanker vessel and three Capesize dry bulk vessels, two Kamsarmax dry bulk vessels, and three Panamax dry bulk vessels, with an aggregate cargo-carrying capacity of approximately 1,004,289 dwt.